news

 
Featured
Vaccine pioneer to give Racker Lecture Oct. 3

Ef Racker Lectures

AI reverse-engineers antibodies

Click HERE to view pdf.

An AI tool saves time in improving protein drugs
New AI approach optimizes antibody drugs
Turning vaccine design on its head

Click HERE to view pdf.

Flipping hemagglutinin on its head

Click HERE to view pdf.

Outrunning the next pandemic
Try This Antibody Over Here
Perfecting antibodies with language models

Click HERE to view pdf.

Learning to ‘speak amino acid’: How language models can change our approach to medicine
Protein language models guide directed antibody evolution

Clink HERE to view pdf.

Computing Our Way to Antibodies
How generative AI is building better antibodies
Durable, low-cost COVID-19 vaccine could help fill in gaps around the world
Meet the 2022 STAT Wunderkinds
Molecular makeover makes wimpy antibody a SARS-CoV-2 tackler
Buzz Baldwin Obituary
A new lease on life for an HIV-neutralizing antibody class and vaccine target
COVID-19 vaccines mostly effective against new strains, researchers say
Stanford researchers pioneer nanoparticle vaccine for COVID-19
Single-dose COVID-19 vaccine triggers antibody response in mice
Stanford single-dose nanoparticle vaccine for COVID-19
High-risk, high-reward grants awarded to four Stanford researchers
Interdisciplinary scientific collaboration at Stanford: Developing an antibody test for COVID-19
ChEM-H researchers take first steps toward new cancer drug
New Stanford ChEM-H building opening
PMD featured in This Week in Virology (TWiV) Podcast!
New approach by Stanford researchers could lead to a lifetime flu vaccine
Innovative Medicines Accelerator at Stanford
2018 Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences